Maarten J. Postma

Research interests

Publications

• The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019

  The Lancet Regional Health - Europe · 2022 · 10.1016/j.lanepe.2022.100341

• Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy

  Expert Review of Pharmacoeconomics & Outcomes Research · 2020 · 10.1080/14737167.2020.1819793

• A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1907096

• Global Burden of Multiple Myeloma

  JAMA Oncology · 2018 · https://doi.org/10.1001/jamaoncol.2018.2128

• A report on the status of vaccination in Europe

  Vaccine · 2018 · https://doi.org/10.1016/j.vaccine.2018.06.044

• Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

  The Lancet Neurology · 2018 · https://doi.org/10.1016/s1474-4422(18)30295-3

• Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

  The Lancet Infectious Diseases · 2018 · https://doi.org/10.1016/s1473-3099(18)30310-4

• Reducing the costs of chronic kidney disease while delivering quality health care: a call to action

  Nature Reviews Nephrology · 2017 · 10.1038/nrneph.2017.63

• The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship

  Intensive Care Medicine · 2017 · https://doi.org/10.1007/s00134-017-4682-7

• Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis

  Vaccine · 2015 · https://doi.org/10.1016/j.vaccine.2015.05.001

• The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges

  Expert Review of Pharmacoeconomics & Outcomes Research · 2013 · https://doi.org/10.1586/erp.13.20

• Clinical and economic impact of non-adherence in COPD: A systematic review

  Respiratory Medicine · 2013 · 10.1016/j.rmed.2013.08.044

• Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case

  European Child & Adolescent Psychiatry · 2013 · https://doi.org/10.1007/s00787-013-0477-8

• Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5

  Value in Health · 2012 · 10.1016/j.jval.2012.06.011

• Dynamic Transmission Modeling

  Medical Decision Making · 2012 · https://doi.org/10.1177/0272989x12454578

• Preventable hospital admissions related to medication (HARM): Cost analysis of the HARM study

  Value in Health · 2011 · https://doi.org/10.1016/j.jval.2010.10.024

• Sodium Intake, ACE Inhibition, and Progression to ESRD

  Journal of the American Society of Nephrology · 2011 · 10.1681/asn.2011040430

• Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

  BMJ · 2010 · https://doi.org/10.1136/bmj.c2509

• Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening

  Human Reproduction Update · 2009 · 10.1093/humupd/dmp035

• Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model

  Value in Health · 2008 · https://doi.org/10.1111/j.1524-4733.2008.00437.x

• Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)

  Clinical Therapeutics · 2006 · https://doi.org/10.1016/j.clinthera.2006.03.012

• Need for differential discounting of costs and health effects in cost effectiveness analyses

  BMJ · 2005 · 10.1136/bmj.331.7514.446

• Comparative Model-based Analysis of Screening Programs for Chlamydia trachomatis Infections

  American Journal of Epidemiology · 2001 · https://doi.org/10.1093/aje/153.1.90

• Current and future medical costs of asthma and chronic obstructive pulmonary disease in the Netherlands

  Respiratory Medicine · 1999 · https://doi.org/10.1016/s0954-6111(99)90262-7

• The dynamic mean-field density functional method and its application to the mesoscopic dynamics of quenched block copolymer melts

  The Journal of Chemical Physics · 1997 · 10.1063/1.473129

Current projects

No projects listed.